Skip to main content
. 2020 Nov 21;193:104343. doi: 10.1016/j.jpubeco.2020.104343

Table A14.

Robustness to Excluding Most Affected Countries (i.e. excluding top 5 percentile).

(1) (2) (3) (4) (5) (6)
Outcome → Confidence in scientists Scientists working for private companies benefit the public Scientists working for private companies are honest Scientists working for universities benefit the public Scientists working for universities are honest Scientists to find out accurate information
Exposure to Epidemic (18–25) −3.427** −1.326*** −1.965*** −0.580 −3.269*** −1.413**
(1.351) (0.313) (0.489) (0.463) (0.451) (0.667)
Observations 79,223 77,719 73,214 77,537 72,531 80,286



(1) (2) (3) (4) (5) (6)

Outcome → Have trust in science Science and technology will help improve life Studying diseases is a part of science Have trust in doctors and nurses Have trust in hospitals and health clinics Have trust in traditional healers

Exposure to Epidemic (18–25) 0.122 0.551 0.189 1.569 1.290 −0.711
(0.468) (0.473) (0.364) (1.235) (1.360) (0.528)
Observations 81,346 82,578 84,246 87,743 85,761 83,696

Notes: Results use the Gallup sampling weights and robust standard errors are clustered at the country level. Specification is Column 3 of Table 1.Source: The most affected countries are * Madagascar, Philippines, Niger, Zimbabwe, Bolivia, Chad, and Republic of Congo. Wellcome Global Monitor, 2018 and EM-DAT International Disaster Database, 1970–2017. * significant at 10%; ** significant at 5%; *** significant at 1%.